Disseminated tuberculosis after anti-TNFα treatment

This publication has 5 references indexed in Scilit:

• Safety analyses of adalimumab (HUMIRA) in global clinical trials and US postmarketing surveillance of patients with rheumatoid arthritis
  Annals of the Rheumatic Diseases, 2006
• Use in routine clinical practice of two commercial blood tests for diagnosis of infection with Mycobacterium tuberculosis: a prospective study
  The Lancet, 2006
• BTS recommendations for assessing risk and for managing Mycobacterium tuberculosis infection and disease in patients due to start anti-TNF- treatment
  Thorax, 2005
• Tuberculosis following the Use of Etanercept, a Tumor Necrosis Factor Inhibitor
  Clinical Infectious Diseases, 2004
• Tuberculosis Associated with Infliximab, a Tumor Necrosis Factor α–Neutralizing Agent
  New England Journal of Medicine, 2001